Ignite Creation Date:
2025-12-24 @ 5:47 PM
Ignite Modification Date:
2025-12-29 @ 6:42 AM
Study NCT ID:
NCT05663268
Status:
COMPLETED
Last Update Posted:
2023-11-29
First Post:
2022-12-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Infliximab Biosimilar in the Treatment of Resistant Hidradenitis Suppurativa
Sponsor:
Services Institute of Medical Sciences, Pakistan
Organization:
Organization Data
Organization:
Class:
OTHER_GOV
Study ID:
IRB/2022/101/SIMS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER_GOV
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None